BIO-RAD LABORATORIES, INC. — Director's Dealing 2021

Sep 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2021-09-01

Reporting Person: ERNST TIMOTHY S (EVP, General Counsel & Sec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-02	Bio-Rad A Common Stock	M	361	—	Acquired	1280.0531	Direct
2021-09-02	Bio-Rad A Common Stock	F	125	$825.77	Disposed	1155.0531	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-01	Restricted Stock Units	$0	A	1013	Acquired		Bio-Rad A Common Stock (1013)	Direct
2021-09-01	Non-Qualified Stock Option (right to buy)	$814.95	A	1013	Acquired	2031-09-01	Bio-Rad A Common Stock (1013)	Direct
2021-09-02	Restricted Stock Units	$0	M	361	Disposed		Bio-Rad A Common Stock (361)	Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.

F4: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.

F5: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.